AL, Y., PS, B., SM, C., PS, B., FD, P., & AJ, D. (2017). Characterization of hydroxypropyl-beta-cyclodextrins used in the treatment of Niemann-Pick Disease type C1. PloS one, 12(4), e0175478. https://doi.org/10.1371/journal.pone.0175478
Chicago Style (17th ed.) CitationAL, Yergey, Blank PS, Cologna SM, Backlund PS, Porter FD, and Darling AJ. "Characterization of Hydroxypropyl-beta-cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1." PloS One 12, no. 4 (2017): e0175478. https://doi.org/10.1371/journal.pone.0175478.
MLA (9th ed.) CitationAL, Yergey, et al. "Characterization of Hydroxypropyl-beta-cyclodextrins Used in the Treatment of Niemann-Pick Disease Type C1." PloS One, vol. 12, no. 4, 2017, p. e0175478, https://doi.org/10.1371/journal.pone.0175478.